WEEKLY TRENDSETTER (JUNE 7,2025)
| 2025 | MAY 23 | MAY 30 | Ch % |
| NIFTY | 24853 | 24750 | -0.41 |
| BANK NIFTY | 55398 | 55749 | 0.63 |
| USD/INR | 85.23 | 85.46 | 0.27 |
MARKET REVIEW-The week was largely range bound as higher levels attracted profit taking. Banking did see some spark towards close of week and PSU banks in particular perked up in action. The Bank Nifty is within striking distance of going past the all-time high. Broader market was also healthy. The GDP numbers over the weekend could provide a provide a positive trigger to begin with next week.
BACK TO RESULT SEASON
March quarter results are coming to an end. Let’s explore some of them to get cues of where the stocks could be heading.
Rs in cr, Bracket indicates ch in % against March,24 quarter.
| Company | Revenue | Net profit |
| Schneider Infra | 587(+24) | 55(+1733) |
| Akum Drugs | 1056(+11) | 150 (39loss) |
| C’tum Electronic | 369(+24) | 22(7 loss) |
| Emcure Pharma | 1278(+41) | 140(+382) |
Schneider Infra-The company caters to the heart of power solutions chargers, industrial and building automation, solar and energy space, etc. It has been growing from strength to strength in the last couple of years after a long period of sluggish phases. For the March quarter revenue as well as profits showed a smart growth. Interest costs which were a drag are now well covered and the coming quarters could see debt repayment as well. With an EPS of 11 for FY25 valuation looks stretched but on correction it could attract buying interest.
Akum Drugs -The company which went public in 2024 is a pharmaceutical contract development and manufacturing organization (CDMO) offering a comprehensive range of pharmaceutical products and services in India and overseas. The company primarily provides end-to-end solutions for product development and manufacturing as well as research and development (R&D) of formulations, preparation and submission of regulatory dossiers in the Indian and global markets and other testing services. The company is also engaged in the manufacture and sale of branded drugs and active pharmaceutical ingredients (APIs). The issue was at a price of Rs 679.After a euphoric listing at above Rs 1100, it cracked to Rs 400 before a recovery. While the performance looks good, the market ‘s reaction is still muted. Valuation looks attractive and could be considered as a dark horse.
Centum Electronics (2493)-The company was established in 1995 and has 30+ domain expertise in Electronics Design and manufacturing solutions. With global operations and strong presence in Asia, Europe and North America. In terms of revenue, defence, space & aerospace (55%), transport and automotives (20%), Industrial & energy (16%) and healthcare (9%) completes the gamut of operations. The March quarter with robust margin growth and an EPS of Rs 16.9 for the quarter has seen the stock soaring to an all time high. Given its past erratic history, the company could be perceived to be in the right spaces which could further propel growth. Lower levels should attract investor attention.
Emcure Pharma(1329)-The company has a wide presence in formulations,biologics,APIs .The company went public in 2024 at an issue price of Rs 1008.The company has seen a decent performance for the March quarter .However the broader picture looks different .In the last 5 years the company has seen a surge in revenue but the bottom line has dipped and for FY 25 EPS stands at Rs 17.At current levels valuation looks steep .
NIFTY –The index saw a hurdle above 25000 and any attempt to go past it was arrested. The closing for the week was below 24800 due to some lack lustre beginning to the June series. The coming week should be interesting and a decisive move past 25100 should see the trend becoming bullish and a close below 24500 could see the bears getting into action.
BANK NIFTY-The index was relatively strong as dips below 55000 were bought into. The closing was on a bullish note and the coming week could again see an attempt to go past the 56100 level.
STOCK PICKS
MCX (6602) -The premier exchange for commodities has seen investor buying at every dip. The “exchange” theme has been building momentum with the expected IPO of National Stock Exchange soon. It has broken past its previous high and with momentum likely to continue the scrip could be accumulated for a possible target of 7500
JP Power (15.6) -The stock touched a high of 24 in 2024 before a strong correction saw it touching 12.60. However, buying momentum has resumed and the scrip could be expected to touch 17-18 in the short to medium term. Accumulation at declines could be considered.
Wishing all readers a great week ahead!
Note: Any queries /clarifications may be addressed to stockmasala@gmail.com .
Krish Subramanyam